Evidence map›Paper›PMID 40742121›Full record

ArticleMicrobiology spectrum2025

Single-cell transcriptome analysis of bronchoalveolar lavage during early SARS-CoV-2 infection.

Sadia Akter, Mushtaq Ahmed, Dhiraj K Singh, Kuldeep S Chauhan, Deepak Kaushal, Shabaana A Khader

Abstract read
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sadia Akter *Department of Microbiology, The University of Chicago, Chicago, Illinois, USA.ORCID 0000-0002-7296-7304
Mushtaq Ahmed *Department of Microbiology, The University of Chicago, Chicago, Illinois, USA.ORCID 0009-0005-0231-6898
Dhiraj K SinghSouthwest National Primate Research Center and Host Pathogen Interactions Program, Texas Biomedical Research Institute, San Antonio, Texas, USA.
Kuldeep S ChauhanDepartment of Microbiology, The University of Chicago, Chicago, Illinois, USA.
Deepak KaushalSouthwest National Primate Research Center and Host Pathogen Interactions Program, Texas Biomedical Research Institute, San Antonio, Texas, USA.ORCID 0000-0003-3521-1257
Shabaana A KhaderDepartment of Microbiology, The University of Chicago, Chicago, Illinois, USA.ORCID 0000-0002-9545-4982

Funding

The Southwest National Primate Research Center Supplement- Infrastructure improvements of ABSL2 holding areasP51OD011133 · OD · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI Larry S. Schlesinger · 2012 to 2026
$129.7M
ROLE OF INDUCIBLE BRONCHUS ASSOCIATED LYMPHOID TISSUE IN LATENT TUBERCULOSISR01AI111914 · NIAID · WASHINGTON UNIVERSITY · PI KAUSHAL, DEEPAK, KHADER, SHABAANA A. · 2015 to 2025
$11.1M
ROLE OF IL-17 IN PROTECTIVE VACCINE-INDUCED IMMUNE RESPONSES AGAINST TUBERCULOSISR01HL105427 · NHLBI · WASHINGTON UNIVERSITY · PI KHADER, SHABAANA A. · 2011 to 2025
$5.9M
The Role of Group 3 Innate Lymphoid cells (ILC3) in TuberculosisR01AI134236 · NIAID · WASHINGTON UNIVERSITY · PI COLONNA, MARCO, KHADER, SHABAANA A. · 2017 to 2021
$4.4M
Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosisR01AI155024 · NIAID · WASHINGTON UNIVERSITY · PI KAUSHAL, DEEPAK, KHADER, SHABAANA A. · 2020 to 2024
$4.1M
COMMON IMMUNE CORRELATES OF RISK OF TB DISEASE IN ANIMAL MODELS AND HUMANSR01AI123780 · NIAID · WASHINGTON UNIVERSITY · PI KAUSHAL, DEEPAK, KHADER, SHABAANA A. · 2016 to 2019
$2.9M
Role of Lung Repair and Regeneration Pathways in TuberculosisR21AI174034 · NIAID · UNIVERSITY OF CHICAGO · PI AHMED, MUSHTAQ · 2024 to 2025
$451k
NHLBI NIH HHS R01 HL105427NIAID NIH HHS R01 AI111914NIAID NIH HHS R01 AI123780NIAID NIH HHS R01 AI134236NIAID NIH HHS R01 AI155024NIAID NIH HHS R21 AI174034NIH HHS AI134236-03S1NIH HHS AI134236-05S1NIH HHS AI174034-01A1NIH HHS P51 OD011133
6 · The paper itself

Abstract

The COVID-19 pandemic, triggered by the SARS-CoV-2 virus, has led to global consequences since its emergence in late 2019, impacting health, economies, and societies worldwide. Understanding the early responses following infection will provide crucial insights into the immune mechanisms governing disease progression and protection. We employed the single-cell RNA-sequencing approach using bronchoalveolar lavage cells of rhesus macaques at 0-3 days post-infection (dpi) in a non-human primate model of SARS-CoV-2. Our results show the increased abundance of two subsets of macrophages that express IFN-responsive gene signatures, inflammatory dendritic cells (DCs), plasmacytoid DCs, and conventional DCs at 3 dpi, coinciding with peak viremia. Moreover, our investigation underscores the enrichment of IFN-α/β, IFN-γ, and IL-1 signaling pathways within myeloid populations at 2-3 dpi in comparison to baseline. These findings substantially deepen our comprehension, elucidating the transcriptional landscape at the single-cell level during the early phases of COVID-19 within a highly relevant model. IMPORTANCE: Understanding the immune response in the early stages of COVID-19 is crucial for developing better treatments and vaccines. In this study, we used advanced single-cell RNA sequencing to examine the immune cells in the lungs of rhesus macaques, a model for human SARS-CoV-2 infection, within the first few days after infection. We identify key immune cell types, such as macrophages and dendritic cells, that are activated early on and produce important signals to fight the virus. These findings help clarify how the immune system responds to SARS-CoV-2 at the single-cell level, offering valuable insights that could guide future therapeutic approaches.

Indexed as

Bronchoalveolar Lavage FluidCOVID-19SARS-CoV-2Single-Cell AnalysisTranscriptomeAnimalsDendritic CellsDisease Models, AnimalGene Expression ProfilingHumansLungMacaca mulattaMacrophagesSingle-Cell Gene Expression AnalysisCOVID-19interferoninterleukinsmyeloidSARS-CoV-2single-cell RNA-seq

Identifiers

PMID40742121
PMCPMC12403745

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.